In addition, immunohistochemical analyses in paired tumour biopsies taken before and during weekly dosing (20, 50, or 70 mg) confirmed inhibition of S6K1 at doses ⩾20 mg (Tabernero et al, 2008). The gene discussed is RPS6KB1; the disease is neoplasm.